ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Super-Enhancer Reprograming Driven by SOX9 and TCF7L2 Represents Transcription-Targeted Therapeutic Vulnerability for Treating Gallbladder Cancer.

Siyuan Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.